(S1 (S (S (NP (JJ Mammalian) (NN thioredoxin)) (VP (VBZ is) (NP (NP (DT a) (JJ direct) (NN inhibitor)) (PP (IN of) (NP (NP (NP (JJ apoptosis) (NN signal-regulating) (NN kinase)) (PRN (-LRB- -LRB-) (NP (VB ASK)) (-RRB- -RRB-))) (CD 1)))))) (. .)))
(S1 (S (S (NP (NP (NP (NN Apoptosis) (JJ signal-regulating) (NN kinase)) (PRN (-LRB- -LRB-) (NP (VB ASK)) (-RRB- -RRB-))) (CD 1)) (VP (VBD was) (ADVP (RB recently)) (VP (VBN identified) (PP (IN as) (NP (NP (DT a) (JJ mitogen-activated) (NN protein) (-LRB- -LRB-) (NN MAP) (-RRB- -RRB-) (NN kinase) (NN kinase) (NN kinase)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ activates) (NP (NP (NP (DT the) (NN c-Jun) (JJ N-terminal) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN JNK)) (-RRB- -RRB-))) (CC and) (NP (NN p38) (NN MAP) (NN kinase) (NNS pathways)))) (CC and) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (ADJP (NN tumor) (NN necrosis) (NN factor) (-LRB- -LRB-) (NN TNF) (-RRB- -RRB-) (JJ -alpha-induced)) (NN apoptosis))))))))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (NP (DT the) (NN mechanism)) (VP (VBG regulating) (NP (NN ASK1) (NN activity)))) (VP (VBZ is) (ADJP (JJ unknown)))) (. .)))
(S1 (S (S (PP (IN Through) (NP (NP (JJ genetic) (NN screening)) (PP (IN for) (NP (JJ ASK1-binding) (NNS proteins))))) (, ,) (NP (NP (NP (NN thioredoxin)) (PRN (-LRB- -LRB-) (NP (NN Trx)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN reduction/oxidation) (NN -LRB-redox-RRB--regulatory) (NN protein)) (VP (VBN thought) (S (VP (TO to) (VP (VB have) (NP (JJ anti-apoptotic) (NNS effects))))))) (, ,)) (VP (VBD was) (VP (VBN identified) (PP (IN as) (NP (NP (DT an) (VBG interacting) (NN partner)) (PP (IN of) (NP (NN ASK1)))))))) (. .)))
(S1 (S (S (NP (NN Trx)) (VP (VBD associated) (PP (IN with) (NP (NP (DT the) (JJ N-terminal) (NN portion)) (PP (IN of) (NP (NN ASK1))))) (ADVP (ADVP (FW in) (FW vitro)) (CC and) (ADVP (FW in) (FW vivo))))) (. .)))
(S1 (S (S (NP (NP (NN Expression)) (PP (IN of) (NP (NN Trx)))) (VP (VBD inhibited) (NP (NP (NN ASK1) (NN kinase) (NN activity)) (CC and) (NP (DT the) (JJ subsequent) (JJ ASK1-dependent) (NN apoptosis))))) (. .)))
(S1 (S (S (NP (NP (NN Treatment)) (PP (IN of) (NP (NNS cells))) (PP (IN with) (NP (NN N-acetyl-L-cysteine)))) (ADVP (RB also)) (VP (VBD inhibited) (NP (NP (NP (ADJP (ADJP (NN serum) (JJ withdrawal-)) (, ,) (ADJP (NN TNF-alpha-) (CC and) (NN hydrogen) (JJ peroxide-induced))) (NN activation)) (PP (IN of) (NP (NN ASK1)))) (CONJP (RB as) (RB well) (IN as)) (NP (NN apoptosis))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN Trx)) (CC and) (NP (NN ASK1))))) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (RB highly) (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN redox) (NN status)) (PP (IN of) (NP (NN Trx)))))))))))) (. .)))
(S1 (S (S (ADVP (RB Moreover)) (, ,) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN Trx)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN activation)) (PP (IN of) (NP (JJ endogenous) (NN ASK1) (NN activity))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NN Trx)) (VP (VBZ is) (NP (NP (DT a) (JJ physiological) (NN inhibitor)) (PP (IN of) (NP (NN ASK1))))))))))) (. .)))
(S1 (S (S (NP (DT The) (NN evidence) (SBAR (IN that) (S (NP (NN Trx)) (VP (VBZ is) (NP (NP (DT a) (JJ negative) (NN regulator)) (PP (IN of) (NP (NN ASK1)))))))) (VP (VBZ suggests) (NP (NP (NP (JJ possible) (NNS mechanisms)) (PP (IN for) (NP (NP (NN redox) (NN regulation)) (PP (IN of) (NP (DT the) (NN apoptosis) (NN signal) (NN transduction) (NN pathway)))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS antioxidants))) (PP (IN against) (NP (NP (NN cytokine-)) (CC and) (NP (JJ stress-induced) (NN apoptosis)))))))) (. .)))
